Skip to content

Comparison of 2 different doses of dexmedatomidine with 0.5 percent levobpivacaine for post operative analgesia

"Comparison of two different doses of Dexmedetomidine combined with 0.5 % Levobupivacaine for post operative analgesia in ultrasound guided supraclavicular brachial plexus block-A double blinded randomized cantrolled study"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025249
Enrollment
56
Registered
2020-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: S598- Other specified injuries of elbowand forearm

Interventions

Intervention1: ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK: For upperlimb surgeries patients were divided randomly into two groups group D50 and D75,blindling is done with computer generat

Sponsors

CHETTINAD HOSPITAL AND REASERCH INSTITUTE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ASA-1 AND ASA-2 patients undergoing either elective or emergency upperlimb surgical procedure

Exclusion criteria

Exclusion criteria: Pediatric patients Geriatric patients(age more than 70 years) Patients with known comorbities(diabetes,hypertension,asthma,seizure disorder,hypothyroidism) patients who are allergic to local anaesthetic drugs Patients who are not not willing for surgical procedure under regional anaesthesia

Design outcomes

Primary

MeasureTime frame
every 30 min till the onset of painTimepoint: every 30 min after injecting drug till the onset of pain

Secondary

MeasureTime frame
effect on hemodynamics onset and duration of of sensory and motor blokadeTimepoint: From the 0 min till 30 min whn patient complains of pain

Countries

India

Contacts

Public ContactKOTHAMASU SOMBABU

CHETTINAD HOSPITAL AND REASERCH INSTITUTE

ashokk_dr1@yahoo.com9003216741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026